İslam Kalkınma Bankası’nın 2017 yılında kurulan Bilim, Teknoloji ve İnovasyon Dönüşüm Fonu (Islamic Development Bank Science, Technology and Innovation Transform Fund – IsDB-STIF) tarafından ilan edilen 2020 yılı İnovasyon için Dönüşüm Fonu Çağrısı (Transform Fund Call for Innovation 2020), tamamen COVID-19 Salgını ile ilgili olarak üye ülkelerin uzun vadeli hazırlık düzeyini ve mücadelelerini geliştirmeye yönelik yenilikçi projeleri destekleyecek olup başvurular devam etmektedir. Konsept Doğrulama aşamasındaki Yeni Fikirlerin Sahipleri ile Bilim, Teknoloji ve İnovasyon alanında Kapasite Artırımı amaçlı Proje Sahiplerine hibe şeklinde destek sağlanacak olup şirket olarak tescil edilmiş Ticarileşme aşamasındaki Teknoloji Sahipleri ile Ölçeklendirme aşamasındaki İnovatif Proje Sahiplerine ise özkaynak sermayesi yatırımı şeklinde destek sağlanacaktır.

Tanıtıcı video: https://youtu.be/6lv_ptVlFRM

Desteklenecek öncelik alanları:

• The application of advanced technology
• Innovative health supply chain management systems
• Development of Low-cost rapid tests and screening methods
• Capacity building interventions

Son başvuru tarihi: 31 Mayıs 2020, Pazar

Duyuru: https://www.isdb-engage.org/en/challenge/call-for-innovation-via-transform-fund-2020

Başvuru Kılavuzu: https://s3-eu-west-1.amazonaws.com/skipsolabs-idb/frontend/challenge/Enhanced%20Operational%20Guidelines%20English%20%281%29.pdf

Online başvuru sistemi: https://www.isdb-engage.org/en/login

Kimler başvurabilir?

İslam Kalkınma Bankası’na Üye Ülkelerde mukim;

• Bilim insanları
• Araştırma Merkezleri
• Üniversiteler
• Girişimciler

Öncelik alanları:

Öncelik alanı	Örnek proje konular
The application of advanced technology	IoT, Big Data blockchain and Artificial Intelligence to track and monitor the spread of COVID-19 and other emerging Infectious diseases for improved diseases surveillance systems and patient care
Innovative health supply chain management systems	Powerful search engine of medical supplies, new Biosafety Laboratory Level-3 Design technology and biocontainment
Development of Low-cost rapid tests and screening methods	Point-of-Care rapid tests, molecular tests and diagnostic test quality, for early detection, diagnostic, treatment and prevention solutions including vaccine production for COVID-19 and future emerging highly infectious diseases
Capacity building interventions	Capacity building interventions targeted at improving operational capacities of health care providers in the field epidemiology and infection control management of highly pathogenic cases, such as training, deployment of software applications, awareness campaigns, service delivery or research centres

Destekleme:

Aşama	Açıklama	Uygun yararlanıcı türleri	Kriterler	Destek/Yatırım Türü	Finansman tutarı
New Ideas with Proof of Concept	This category supports innovative and practical ideas with a Proof of Concept that need initial funding/seed money for pilot project interventions/ development solutions. The solution should have a clearly articulated path to the development of a self-sustaining business or a plan to develop a partnership with an existing business. Some of the funds could be used to help set up a company and develop or refine the strategy	Bilim Adamları İnovasyon Yapan Kişiler	innovativeness potential impact Doable and practical replicable and scalable patentable with commercial potential sustainable	Hibe	$50.000 – $100.000
Scaling Up of Innovative Projects	This category is open to applications from companies with successfully piloted products or services which need additional capital to refine, replicate and/or scale up the product/service in MCs, especially in LDMCs.	Tescil Edilmiş Tüzel Kişiler*	innovativeness potential impact replicability and scalability patent position business plan and market opportunity strength of the management team exit potential	Özkaynak sermaye iştiraki/Özsermaye benzeri iştirak yatırımları	$300.000’e kadar
Commercialization of Technology	This category is designed to support companies which have successfully scaled up an innovative product or service in one or several MCs and requires additional capital for expanding the commercial reach.	Tescil Edilmiş Şirketler**	innovativeness potential impact replicability and scalability patent position sustainability strength of the management team exit potential	Özkaynak sermaye iştiraki/Özsermaye benzeri iştirak yatırımları	$1.000.000’a kadar
STI Capacity Building	IsDB member countries require immediate and intensive Capacity Building (CB) support in STI to meet the sustainable development goals. Projects eligible for funding in this category must meet one or more of the following criteria: producing critical mass in STI human resources (including researchers and STI policy makers) strengthening institutional capacity for research and improving science education enhancing knowledge and expertise in spinning-in, adapting, and spinning-out existing technologies and improving scientific cooperation formulating and implementing adequate STI policies that support all the above efforts	Tescil Edilmiş Tüzel Kişiler	innovativeness potential impact implementation plan scalability sustainability	Hibe	$100.000 – $150.000

* Registered legal entity: For any form of an association, corporation, partnership, proprietorship or trust that has legal capacity to enter into agreements, assume and fulfil obligations, bring or be subject to legal claims, and to be held responsible for its actions, and which is registered under the applicable law of the relevant jurisdiction and has legal standing in the eyes of the relevant law and judicial system

** Registered legal company: Is only for companies that are a body corporate or an incorporated business organization registered under the relevant companies act or law of the relevant jurisdiction. It can be any type of company, including and not limited to limited or an unlimited company, private or a public company, but excludes, among other things, sole proprietorship, partnerships, individuals and trusts

Değerlendirme süreci:

• Preliminary Screening: The proposals will be initially reviewed and scored by a set of independent external SDG experts in coordination with the STI Department. During the screening process, the IsDB may contact the applicants (if required) and the STI Department may also seek the opinion of the relevant Departments and entities within the IsDB Group. The screening process will result in a shortlist of applicants under each of the funding categories.
• Evaluation and Selection of “Semi-Finalists”: The shortlisted applications will then be evaluated and scored by the members of the Scientific Advisory Board (SAB) against the qualifying criteria described under each funding category. Subsequently, the top scoring proposals will be designated as “Semi-Finalists.”
• Preliminary Diligence: “Semi-Finalists” will be contacted to provide additional information and clarification regarding their proposals.
• Final Evaluation and Selection of “Finalists”: The SAB will subsequently meet as a group and discuss the semi-finalist proposals in order to choose a subset which will be designated as the “Finalists.”
• BoT Approval to Move Forward: The Finalist’s proposals will be forwarded to the Board of Trustees (BoT) for consideration. The BoT, will decide whether the STI Department can proceed to the final diligence and negotiation step for each individual proposal.
• Final Diligence and Negotiation: Grant finalists that receive approval from the BoT will complete the diligence process and a grant agreement will be generated. If and once a grant agreement has been signed and countersigned, the Finalist will then be designated a “Transform Winner.” Funds will then be forthcoming. Equity investment finalists will continue along the due diligence and negotiation process. If and when an equity deal is signed and closed, the equity investment finalist will then be designated a Transform Winner.” Investment funds will then be forthcoming

Daha fazla bilgi ve sorularınız için: https://www.isdb-engage.org/en/contact_us